Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01018 | Mc-Val-Ala-PAB | 1870916-87-2 |
| Mc-Val-Ala-PAB is a cleavable peptide ADC linker with maleimide for thiol conjugation, Val-Ala dipeptide for enzymatic release, and PAB spacer, optimizing controlled payload delivery. | Inquiry | |
| BADC-01019 | BCN-PEG4-acid | 1881221-47-1 |
| BCN-PEG4-acid is a carboxylic acid-functionalized ADC linker with BCN for fast bioorthogonal cycloaddition, enhancing conjugation efficiency and solubility in antibody-drug conjugates. | Inquiry | |
| BADC-01020 | Boc-Val-Ala-PAB-PNP | 1884578-00-0 |
| Boc-Val-Ala-PAB-PNP is a cleavable peptide ADC linker with PNP ester activation, facilitating efficient amine coupling and tumor-specific enzymatic drug release in antibody-drug conjugates. | Inquiry | |
| BADC-01021 | Fmoc-NH-PEG2-NH2 | 190249-87-7 |
| Fmoc-NH-PEG2-NH2 is a PEG-based ADC linker intermediate with protected amine groups, enabling versatile conjugation strategies for stable antibody-drug conjugate synthesis. | Inquiry | |
| BADC-01022 | PC Biotin-PEG3-azide | 1937270-46-6 |
| PC Biotin-PEG3-azide is a multifunctional ADC linker combining photoreactive groups, biotin affinity tag, and azide chemistry to enable targeted conjugation and purification in antibody-drug conjugate development. | Inquiry | |
| BADC-01023 | Mal-PEG4-Val-Cit-PAB | 1949793-41-2 |
| Mal-PEG4-Val-Cit-PAB is a maleimide-activated cleavable ADC linker with Val-Cit-PAB motif, facilitating site-specific payload release and stable antibody conjugation in therapeutic applications. | Inquiry | |
| BADC-01025 | Fmoc-Ala-Ala-Asn(Trt)-OH | 1951424-92-2 |
| Fmoc-Ala-Ala-Asn(Trt)-OH is a protected peptide linker precursor used in ADC synthesis for site-specific drug release and enhanced conjugate stability. | Inquiry | |
| BADC-01026 | Propargyl-PEG6-acid | 1951438-84-8 |
| Propargyl-PEG6-acid is a hydrophilic linker with an alkyne group for click chemistry and a carboxylic acid for conjugation. Used in ADC linker development to improve payload accessibility and aqueous solubility in therapeutic antibody conjugates. | Inquiry | |
| BADC-01027 | Propargyl-PEG1-SS-PEG1-propargyl | 1964503-40-9 |
| Propargyl-PEG1-SS-PEG1-propargyl offers cleavable disulfide ADC linker properties with terminal alkyne groups, facilitating copper-catalyzed click conjugation and intracellular payload release. | Inquiry | |
| BADC-01030 | Fmoc-Asp-NH2 | 200335-40-6 |
| Fmoc-Asp-NH2 is a protected amino acid linker precursor with a free amide group. Frequently employed in peptide-based ADC linker synthesis, it facilitates precise orientation of payloads and enzymatically cleavable designs, supporting highly selective and tunable drug delivery systems. | Inquiry | |
| BADC-01031 | Mal-Sulfo-DBCO | 2028281-86-7 |
| Mal-Sulfo-DBCO is a water-soluble heterobifunctional ADC linker with maleimide and DBCO groups, enabling thiol-specific conjugation and strain-promoted azide-alkyne cycloaddition for site-specific payload attachment. | Inquiry | |
| BADC-01034 | Azido-PEG6-NHS ester | 2055014-64-5 |
| Azido-PEG6-NHS ester is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Azido-PEG6-NHS ester is also a PEG- and Alkyl/ether based PROTAC linker that can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-01035 | Propargyl-PEG8-acid | 2055014-94-1 |
| Propargyl-PEG8-acid features an extended PEG8 spacer for improved solubility and reduced aggregation in ADCs. The alkyne group supports efficient click reactions for covalent drug-antibody linkage in bioconjugation applications. | Inquiry | |
| BADC-01036 | Bis-(PEG6-acid)-SS | 2055014-97-4 |
| Bis-(PEG6-acid)-SS is a PEG-based cleavable ADC linker featuring disulfide bonds for triggered drug release. Its PEGylated structure improves biocompatibility and stability in antibody-drug conjugates targeting cancer cells. | Inquiry | |
| BADC-01037 | Acid-PEG3-SS-PEG3-acid | 2055014-98-5 |
| Acid-PEG3-SS-PEG3-acid is a PEGylated cleavable ADC linker with terminal acid groups and disulfide bonds. It enhances conjugation flexibility and enables controlled payload release in antibody-drug conjugates. | Inquiry | |
| BADC-01038 | Azido-PEG4-Val-Cit-PAB-OH | 2055024-64-9 |
| Azido-PEG4-Val-Cit-PAB-OH is a cleavable ADC linker designed for controlled drug release via lysosomal enzymes. Featuring a PEG4 spacer and azide functionality, it is ideal for site-specific conjugation in antibody-drug conjugate applications. | Inquiry | |
| BADC-01039 | Azido-PEG3-Val-Cit-PAB-OH | 2055024-65-0 |
| Azido-PEG3-Val-Cit-PAB-OH is a cleavable ADC linker with Val-Cit dipeptide and PAB spacer for enzymatic release, combined with azide and PEG3 for hydrophilicity and click chemistry bioconjugation. | Inquiry | |
| BADC-01040 | Mal-PEG1-Val-Cit-PABC-OH | 2055041-37-5 |
| Mal-PEG1-Val-Cit-PABC-OH is a maleimide-based cleavable ADC linker with PEG spacer and Val-Cit-PABC for targeted drug release. Facilitates thiol conjugation in ADC synthesis for cancer therapy. | Inquiry | |
| BADC-01041 | Mal-PEG2-Val-Cit-amido-PAB-OH | 2055041-38-6 |
| Mal-PEG2-Val-Cit-amido-PAB-OH is a maleimide-activated ADC linker designed for thiol-reactive conjugation. Featuring a cathepsin B-cleavable Val-Cit-PAB motif, it ensures efficient intracellular drug release in antibody-drug conjugates targeting cancer cells. | Inquiry | |
| BADC-01042 | Mal-PEG4-Val-Cit-PAB-OH | 2055041-39-7 |
| Mal-PEG4-Val-Cit-PAB-OH is a maleimide-based PEGylated cleavable ADC linker featuring valine-citrulline for enzymatic drug release, enhancing stability and solubility in antibody-drug conjugates. | Inquiry |
